Terms: = Ovarian cancer AND CREB1, ENSG00000118260, 1385
17 results:
1. CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype.
Trecourt A; Macagno N; Ngo C; Philip CA; Lopez J; Ferreira J; Alves-Vale C; Ray-Coquard I; Genestie C; Agaimy A; Devouassoux-Shisheboran M
Virchows Arch; 2023 Jun; 482(6):967-974. PubMed ID: 37097347
[TBL] [Abstract] [Full Text] [Related]
2. Multi-Omics Analysis Identifying Key Biomarkers in ovarian cancer.
Li JY; Li CJ; Lin LT; Tsui KH
Cancer Control; 2020; 27(1):1073274820976671. PubMed ID: 33297760
[TBL] [Abstract] [Full Text] [Related]
3. Common cancer biomarkers of breast and ovarian types identified through artificial intelligence.
Pawar S; Liew TO; Stanam A; Lahiri C
Chem Biol Drug Des; 2020 Sep; 96(3):995-1004. PubMed ID: 32410355
[TBL] [Abstract] [Full Text] [Related]
4. Frequency and predictors of chemotherapy-associated venous thromboembolism: the prospective PREVENT study.
Kakkos SK; Arnaoutoglou E; Tsolakis IA; Giannoukas A; Papadimitriou CA; Kentepozidis N; Boukovinas I; Kalofonos HP; Labropoulos N; Matsagkas M
Int Angiol; 2020 Apr; 39(2):112-117. PubMed ID: 32057213
[TBL] [Abstract] [Full Text] [Related]
5. Transcriptional Characterization of Stage I Epithelial ovarian cancer: A Multicentric Study.
Calura E; Ciciani M; Sambugaro A; Paracchini L; Benvenuto G; Milite S; Martini P; Beltrame L; Zane F; Fruscio R; Marchette MD; Borella F; Tognon G; Ravaggi A; Katsaros D; Bignotti E; Odicino F; D'Incalci M; Marchini S; Romualdi C
Cells; 2019 Dec; 8(12):. PubMed ID: 31805750
[TBL] [Abstract] [Full Text] [Related]
6. creb1 induced lncRNA HAS2-AS1 promotes epithelial ovarian cancer proliferation and invasion via the miR-466/RUNX2 axis.
Tong L; Wang Y; Ao Y; Sun X
Biomed Pharmacother; 2019 Jul; 115():108891. PubMed ID: 31082772
[TBL] [Abstract] [Full Text] [Related]
7. Effect of the neuropeptide phoenixin and its receptor GPR173 during folliculogenesis.
Nguyen XP; Nakamura T; Osuka S; Bayasula B; Nakanishi N; Kasahara Y; Muraoka A; Hayashi S; Nagai T; Murase T; Goto M; Iwase A; Kikkawa F
Reproduction; 2019 Jul; 158(1):25-34. PubMed ID: 30933929
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathologic Features and Risk Factors for Recurrence of Mucinous Borderline ovarian Tumors: A Retrospective Study With Follow-up of More Than 10 Years.
Sun L; Li N; Song Y; Wang G; Zhao Z; Wu L
Int J Gynecol Cancer; 2018 Nov; 28(9):1643-1649. PubMed ID: 30365456
[TBL] [Abstract] [Full Text] [Related]
9. Long noncoding RNA DQ786243 interacts with miR-506 and promotes progression of ovarian cancer through targeting cAMP responsive element binding protein 1.
Yan H; Silva MA; Li H; Zhu L; Li P; Li X; Wang X; Gao J; Wang P; Zhang Z
J Cell Biochem; 2018 Dec; 119(12):9764-9780. PubMed ID: 30105876
[TBL] [Abstract] [Full Text] [Related]
10. Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.
Lee YC; Bressel M; Grant P; Russell P; Smith C; Picken S; Camm S; Kiely BE; Milne RL; McLachlan SA; Hickey M; Friedlander ML; Hopper JL; Phillips KA;
Fam Cancer; 2017 Oct; 16(4):461-469. PubMed ID: 28285341
[TBL] [Abstract] [Full Text] [Related]
11. InFlo: a novel systems biology framework identifies cAMP-creb1 axis as a key modulator of platinum resistance in ovarian cancer.
Dimitrova N; Nagaraj AB; Razi A; Singh S; Kamalakaran S; Banerjee N; Joseph P; Mankovich A; Mittal P; DiFeo A; Varadan V
Oncogene; 2017 Apr; 36(17):2472-2482. PubMed ID: 27819677
[TBL] [Abstract] [Full Text] [Related]
12. The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian-but not endometrial cancer.
Gansmo LB; Bjørnslett M; Halle MK; Salvesen HB; Dørum A; Birkeland E; Hveem K; Romundstad P; Vatten L; Lønning PE; Knappskog S
Tumour Biol; 2016 Aug; 37(8):10697-702. PubMed ID: 26867771
[TBL] [Abstract] [Full Text] [Related]
13. Salt-inducible kinase 2 regulates mitotic progression and transcription in prostate cancer.
Bon H; Wadhwa K; Schreiner A; Osborne M; Carroll T; Ramos-Montoya A; Ross-Adams H; Visser M; Hoffmann R; Ahmed AA; Neal DE; Mills IG
Mol Cancer Res; 2015 Apr; 13(4):620-635. PubMed ID: 25548099
[TBL] [Abstract] [Full Text] [Related]
14. Angiomatoid fibrous histiocytoma: unusual sites and unusual morphology.
Chen G; Folpe AL; Colby TV; Sittampalam K; Patey M; Chen MG; Chan JK
Mod Pathol; 2011 Dec; 24(12):1560-70. PubMed ID: 21822206
[TBL] [Abstract] [Full Text] [Related]
15. Predictive value of CA 125 and CA 72-4 in ovarian borderline tumors.
Lenhard MS; Nehring S; Nagel D; Mayr D; Kirschenhofer A; Hertlein L; Friese K; Stieber P; Burges A
Clin Chem Lab Med; 2009; 47(5):537-42. PubMed ID: 19317653
[TBL] [Abstract] [Full Text] [Related]
16. Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoter.
Suen TC; Goss PE
J Biol Chem; 2000 Mar; 275(9):6600-7. PubMed ID: 10692468
[TBL] [Abstract] [Full Text] [Related]
17. Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers.
Engelman JA; Zhang XL; Lisanti MP
FEBS Lett; 1998 Oct; 436(3):403-10. PubMed ID: 9801158
[TBL] [Abstract] [Full Text] [Related]
